Literature DB >> 3773007

Use of amnion for the treatment of Stevens-Johnson syndrome.

J K Prasad, I Feller, P D Thomson.   

Abstract

Stevens-Johnson syndrome (toxic epidermal necrolysis) has similar pathophysiologic characteristics to extensive partial-thickness burns. Successful treatment of a 6-year-old with this syndrome denuding 95% of her body surface, with 6.5 square feet of amnion is reported.

Entities:  

Mesh：

Year:  1986        PMID： 3773007     DOI： 10.1097/00005373-198610000-00016

Source DB:  PubMed          Journal:  J Trauma        ISSN： 0022-5282


  7 in total

Review 1.  Amniotic membrane transplantation.

Authors:  H S Dua; A Azuara-Blanco
Journal:  Br J Ophthalmol       Date:  1999-06       Impact factor: 4.638

2.  Immunosuppressive properties of human amniotic membrane for mixed lymphocyte reaction.

Authors:  M Ueta; M-N Kweon; Y Sano; C Sotozono; J Yamada; N Koizumi; H Kiyono; S Kinoshita
Journal:  Clin Exp Immunol       Date:  2002-09       Impact factor: 4.330

3.  Transplantation of amniotic membrane and limbal autograft for patients with recurrent pterygium associated with symblepharon.

Authors:  J Shimazaki; N Shinozaki; K Tsubota
Journal:  Br J Ophthalmol       Date:  1998-03       Impact factor: 4.638

Review 4.  Human Perinatal-Derived Biomaterials.

Authors:  Marc C Moore; Aurore Van De Walle; Jerry Chang; Cassandra Juran; Peter S McFetridge
Journal:  Adv Healthc Mater       Date:  2017-08-07       Impact factor: 9.933

Review 5.  Clinical features and management of severe dermatological reactions to drugs.

Authors:  M C Raviglione; A Pablos-Mendez; R Battan
Journal:  Drug Saf       Date:  1990 Jan-Feb       Impact factor: 5.606

6.  Rate of epithelialisation and re-operations in corneal ulcers treated with amniotic membrane transplantation combined with botulinum toxin-induced ptosis.

Authors:  Thomas Fuchsluger; Emre Tuerkeli; Henrike Westekemper; Joachim Esser; Klaus-Peter Steuhl; Daniel Meller
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-01-12       Impact factor: 3.535

Review 7.  Current Perspectives on Severe Drug Eruption.

Authors:  Jingzhan Zhang; Zixian Lei; Chen Xu; Juan Zhao; Xiaojing Kang
Journal:  Clin Rev Allergy Immunol       Date:  2021-07-17       Impact factor: 8.667
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.